Literature DB >> 30548704

Volumetric 18 F-FDG-PET parameters as predictors of locoregional failure in low-risk HPV-related oropharyngeal cancer after definitive chemoradiation therapy.

Thong Chotchutipan1,2, Benjamin S Rosen1, Peter G Hawkins1, Jae Y Lee1,3, Anjali L Saripalli1, Dharmesh Thakkar1, Avraham Eisbruch1, Issam El Naqa1, Michelle L Mierzwa1.   

Abstract

BACKGROUND: We sought to investigate the prognostic value of volumetric positron emission tomography (PET) parameters in patients with human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC) and a ≤10 pack-year smoking history treated with chemoradiation.
METHODS: A total of 142 patients were included. Maximum standardized uptake value, metabolic tumor volume, and total lesion glycolysis (TLG) of the primary tumor, involved regional lymph nodes, and total lesion were calculated. Cox proportional hazard modeling was used to evaluate associations of clinical and PET parameters with locoregional failure-free survival (LRFFS), distant metastasis-free survival (DMFS), and overall survival (OS).
RESULTS: On univariate analysis, volumetric PET parameters were significantly associated with all endpoints, and 8th edition American Joint Committee on Cancer/Union Internationale Contre le Cancer staging was significantly associated with DMFS and OS. On multivariate analysis, total lesion TLG was significantly associated with LRFFS, while staging was most significantly prognostic for DMFS and OS.
CONCLUSION: Volumetric PET parameters are uniquely prognostic of LRFFS in low-risk HPV-related OPSCC and may be useful for directing de-intensification strategies.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  FDG-PET; OPSCC; TNM staging; local control; radiation oncology

Year:  2018        PMID: 30548704      PMCID: PMC6411288          DOI: 10.1002/hed.25505

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  30 in total

1.  Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation.

Authors:  Brian O'Sullivan; Shao Hui Huang; Bayardo Perez-Ordonez; Christine Massey; Lillian L Siu; Ilan Weinreb; Andrew Hope; John Kim; Andrew J Bayley; Bernard Cummings; Jolie Ringash; Laura A Dawson; B C John Cho; Eric Chen; Jonathan Irish; Ralph W Gilbert; Angela Hui; Fei-Fei Liu; Helen Zhao; John N Waldron; Wei Xu
Journal:  Radiother Oncol       Date:  2012-03-10       Impact factor: 6.280

2.  Value of Intratumoral Metabolic Heterogeneity and Quantitative 18F-FDG PET/CT Parameters to Predict Prognosis in Patients With HPV-Positive Primary Oropharyngeal Squamous Cell Carcinoma.

Authors:  Esther Mena; Mehdi Taghipour; Sara Sheikhbahaei; Abhinav K Jha; Arman Rahmim; Lilja Solnes; Rathan M Subramaniam
Journal:  Clin Nucl Med       Date:  2017-05       Impact factor: 7.794

3.  An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer center: a staging system in need of repair.

Authors:  Kristina R Dahlstrom; Gabriel Calzada; Jennifer D Hanby; Adam S Garden; Bonnie S Glisson; Guojun Li; Dianna B Roberts; Randal S Weber; Erich M Sturgis
Journal:  Cancer       Date:  2012-06-26       Impact factor: 6.860

4.  Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.

Authors:  Brian O'Sullivan; Shao Hui Huang; Jie Su; Adam S Garden; Erich M Sturgis; Kristina Dahlstrom; Nancy Lee; Nadeem Riaz; Xin Pei; Shlomo A Koyfman; David Adelstein; Brian B Burkey; Jeppe Friborg; Claus A Kristensen; Anita B Gothelf; Frank Hoebers; Bernd Kremer; Ernst-Jan Speel; Daniel W Bowles; David Raben; Sana D Karam; Eugene Yu; Wei Xu
Journal:  Lancet Oncol       Date:  2016-02-27       Impact factor: 41.316

5.  The impact of late treatment-toxicity on generic health-related quality of life in head and neck cancer patients after radiotherapy.

Authors:  Bram L T Ramaekers; Manuela A Joore; Janneke P C Grutters; Piet van den Ende; Jos de Jong; Ruud Houben; Philippe Lambin; Miranda Christianen; Ivo Beetz; Madelon Pijls-Johannesma; Johannes A Langendijk
Journal:  Oral Oncol       Date:  2011-06-17       Impact factor: 5.337

6.  18F-FDG PET/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma.

Authors:  Remy Lim; Anne Eaton; Nancy Y Lee; Jeremy Setton; Nisha Ohri; Shyam Rao; Richard Wong; Matthew Fury; Heiko Schöder
Journal:  J Nucl Med       Date:  2012-08-14       Impact factor: 10.057

7.  E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.

Authors:  Shanthi Marur; Shuli Li; Anthony J Cmelak; Maura L Gillison; Weiqiang J Zhao; Robert L Ferris; William H Westra; Jill Gilbert; Julie E Bauman; Lynne I Wagner; David R Trevarthen; Jahagirdar Balkrishna; Barbara A Murphy; Nishant Agrawal; A Dimitrios Colevas; Christine H Chung; Barbara Burtness
Journal:  J Clin Oncol       Date:  2016-12-28       Impact factor: 44.544

8.  De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis of current clinical trials.

Authors:  Liam Masterson; Daniel Moualed; Zi Wei Liu; James E F Howard; Raghav C Dwivedi; James R Tysome; Richard Benson; Jane C Sterling; Holger Sudhoff; Piyush Jani; Peter K C Goon
Journal:  Eur J Cancer       Date:  2014-08-01       Impact factor: 9.162

9.  Prognostic value of midtreatment FDG-PET in oropharyngeal cancer.

Authors:  Erqi L Pollom; Jie Song; Benjamin Y Durkee; Sonya Aggarwal; Timothy Bui; Rie von Eyben; Ruijiang Li; David M Brizel; Billy W Loo; Quynh-Thu Le; Wendy Y Hara
Journal:  Head Neck       Date:  2016-04-04       Impact factor: 3.147

10.  Phase 2 Trial of De-intensified Chemoradiation Therapy for Favorable-Risk Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.

Authors:  Bhishamjit S Chera; Robert J Amdur; Joel Tepper; Bahjat Qaqish; Rebecca Green; Shannon L Aumer; Neil Hayes; Jared Weiss; Juneko Grilley-Olson; Adam Zanation; Trevor Hackman; William Funkhouser; Nathan Sheets; Mark Weissler; William Mendenhall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-08-22       Impact factor: 7.038

View more
  6 in total

Review 1.  Advances in Imaging for HPV-Related Oropharyngeal Cancer: Applications to Radiation Oncology.

Authors:  Travis C Salzillo; Nicolette Taku; Kareem A Wahid; Brigid A McDonald; Jarey Wang; Lisanne V van Dijk; Jillian M Rigert; Abdallah S R Mohamed; Jihong Wang; Stephen Y Lai; Clifton D Fuller
Journal:  Semin Radiat Oncol       Date:  2021-10       Impact factor: 5.421

2.  Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy.

Authors:  Gabriel Adrian; Henrik Carlsson; Elisabeth Kjellén; Johanna Sjövall; Björn Zackrisson; Per Nilsson; Maria Gebre-Medhin
Journal:  Radiat Oncol       Date:  2022-06-14       Impact factor: 4.309

3.  Analysis of PET parameters as prognosticators of survival and tumor extent in Oropharyngeal Cancer treated with surgery and postoperative radiotherapy.

Authors:  Kyu Hye Choi; Jin Ho Song; Eun Young Park; Ji Hyun Hong; Ie Ryung Yoo; Youn Soo Lee; Dong-Il Sun; Min-Sik Kim; Yeon-Sil Kim
Journal:  BMC Cancer       Date:  2021-03-25       Impact factor: 4.430

4.  Predictive Values of MRI and PET Derived Quantitative Parameters for Patterns of Failure in Both p16+ and p16- High Risk Head and Neck Cancer.

Authors:  Yue Cao; Madhava Aryal; Pin Li; Choonik Lee; Matthew Schipper; Peter G Hawkins; Christina Chapman; Dawn Owen; Aleksandar F Dragovic; Paul Swiecicki; Keith Casper; Francis Worden; Theodore S Lawrence; Avraham Eisbruch; Michelle Mierzwa
Journal:  Front Oncol       Date:  2019-11-14       Impact factor: 6.244

5.  Correlation between histogram-based DCE-MRI parameters and 18F-FDG PET values in oropharyngeal squamous cell carcinoma: Evaluation in primary tumors and metastatic nodes.

Authors:  Antonello Vidiri; Emma Gangemi; Emanuela Ruberto; Rosella Pasqualoni; Rosa Sciuto; Giuseppe Sanguineti; Alessia Farneti; Maria Benevolo; Francesca Rollo; Francesca Sperati; Filomena Spasiano; Raul Pellini; Simona Marzi
Journal:  PLoS One       Date:  2020-03-02       Impact factor: 3.240

6.  Development and Assessment of a Model for Predicting Individualized Outcomes in Patients With Oropharyngeal Cancer.

Authors:  Lauren J Beesley; Andrew G Shuman; Michelle L Mierzwa; Emily L Bellile; Benjamin S Rosen; Keith A Casper; Mohannad Ibrahim; Sarah M Dermody; Gregory T Wolf; Steven B Chinn; Matthew E Spector; Robert J Baatenburg de Jong; Emilie A C Dronkers; Jeremy M G Taylor
Journal:  JAMA Netw Open       Date:  2021-08-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.